Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Income
$239.0M
Filings
7,220
Unique Clients
123
Active Period
1999–2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Protect College Sports Act of 2026
2026 · third_quarter · Client: UNITED STATES OLYMPIC & PARALYMPIC COMMITTEE
Issues related to Olympic womens and mens collegiate sports. S.4668/H.R.9137, The Protect College Sports Act of 2026.
Client expense: — · Firm income: $60,000
Matched citations: H.R.9137
American Decade of Sports Act
2026 · third_quarter · Client: UNITED STATES OLYMPIC & PARALYMPIC COMMITTEE
Issues related to anti-doping. S.3676, American Decade of Sports Act.
Client expense: — · Firm income: $60,000
Matched citations: S.3676
Protect College Sports Act of 2026
2026 · third_quarter · Client: UNITED STATES OLYMPIC & PARALYMPIC COMMITTEE
Issues related to Olympic womens and mens collegiate sports. S.4668/H.R.9137, The Protect College Sports Act of 2026.
Client expense: — · Firm income: $60,000
Matched citations: S.4668
Surge to Save Newborns Act
2026 · third_quarter · Client: TRAVERE THERAPEUTICS
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. H.R.10571, Surge to Save Newborns Act. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Client expense: — · Firm income: $80,000
Matched citations: H.R.10571
Surge to Save Newborns Act
2026 · third_quarter · Client: TRAVERE THERAPEUTICS
H.R.10571, Surge to Save Newborns Act.
Client expense: — · Firm income: $80,000
Matched citations: H.R.10571
H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit.
Client expense: — · Firm income: $80,000
Matched citations: H.R.1414
New Era of Preventing End-Stage Kidney Disease Act
2026 · third_quarter · Client: TRAVERE THERAPEUTICS
H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.
Client expense: — · Firm income: $80,000
Matched citations: H.R.1518
New Era of Preventing End-Stage Kidney Disease Act
2026 · third_quarter · Client: TRAVERE THERAPEUTICS
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. H.R.10571, Surge to Save Newborns Act. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Client expense: — · Firm income: $80,000
Matched citations: H.R.1518
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. H.R.10571, Surge to Save Newborns Act. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.
Client expense: — · Firm income: $80,000
Matched citations: H.R.946
Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs. Most-Favored Nation and International Reference Pricing proposals. PDUFA/regulatory review process.
Client expense: — · Firm income: $80,000
Matched citations: H.R.946
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
2026 · third_quarter · Client: THE METROHEALTH SYSTEM
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. 340b price transparency issues concerning 340B program rebate proposal. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma care and detrimental impact patient outcomes.
Client expense: — · Firm income: $50,000
Matched citations: H.R.4392
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
2026 · third_quarter · Client: THE METROHEALTH SYSTEM
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Client expense: — · Firm income: $50,000
Matched citations: H.R.4392
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
2026 · third_quarter · Client: THE METROHEALTH SYSTEM
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Client expense: — · Firm income: $50,000
Matched citations: H.R.5371
Medicare Patient Access and Practice Stabilization Act of 2025
2026 · third_quarter · Client: THE METROHEALTH SYSTEM
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Client expense: — · Firm income: $50,000
Matched citations: H.R.879
Improve and Enhance the Work Opportunity Tax Credit Act
2026 · third_quarter · Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Client expense: — · Firm income: $70,000
Matched citations: H.R.1177
Travel Trailer and Camper Tax Parity Act
2026 · third_quarter · Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Client expense: — · Firm income: $70,000
Matched citations: H.R.332
Main Street Tax Certainty Act
2026 · third_quarter · Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Client expense: — · Firm income: $70,000
Matched citations: H.R.703
Travel Trailer and Camper Tax Parity Act
2026 · third_quarter · Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Client expense: — · Firm income: $70,000
Matched citations: S.1314
Improve and Enhance the Work Opportunity Tax Credit Act
2026 · third_quarter · Client: REDWOOD HOLDINGS, LLC FKA REDWOOD CAPITAL INVESTMENTS
Issues related to H.R.1177/S.492, Improve and Enhance the Work Opportunity Tax Credit Act, H.R.703, Main Street Tax Certainty Act, and H.R.332/S.1314, Travel Trailer and Camper Tax Parity Act.
Client expense: — · Firm income: $70,000
Matched citations: S.492
Ensuring Community Access to Pharmacist Services Act
2026 · third_quarter · Client: FUTURE OF PHARMACY COALITION LLC
H.R.3164/S.2426, Advance the Ensuring Access to Pharmacist Services Act.
Client expense: — · Firm income: $80,000
Matched citations: H.R.3164
Equitable Community Access to Pharmacist Services Act
2026 · third_quarter · Client: FUTURE OF PHARMACY COALITION LLC
H.R.3164/S.2426, Advance the Ensuring Access to Pharmacist Services Act.
Client expense: — · Firm income: $80,000
Matched citations: S.2426
SHARE Act of 2026
2026 · third_quarter · Client: FEDERATION OF STATE MEDICAL BOARDS (FSMB)
H.R.2332/S.1101, States Handling Access to Reciprocity for Employment (SHARE) Act. Appropriations for Provider Bridge licensure portability program. AI in Health Care.
Client expense: — · Firm income: $70,000
Matched citations: H.R.2332
SHARE Act of 2025
2026 · third_quarter · Client: FEDERATION OF STATE MEDICAL BOARDS (FSMB)
H.R.2332/S.1101, States Handling Access to Reciprocity for Employment (SHARE) Act. Appropriations for Provider Bridge licensure portability program. AI in Health Care.
Client expense: — · Firm income: $70,000
Matched citations: S.1101
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $150,000
Matched citations: H.R.9102
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
Client expense: — · Firm income: $150,000
Matched citations: H.R.9102
Source: Senate LDA